333
Views
1
CrossRef citations to date
0
Altmetric
Real-World Evidence and Medical Affairs

Commercial impact of adding real-world evidence to clinical trials at regulatory approval: a Markovian-like transition model

ORCID Icon
Pages 1559-1566 | Received 09 Dec 2022, Accepted 26 Jan 2023, Published online: 06 Feb 2023

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.